Benefit of thick liquids in Alzheimer’s disease and dysphagia unclear
May 06, 2024
Patients receiving thick versus thin liquids were less likely to be intubated and more likely to have respiratory complications.
AI ‘promising’ for use in geriatrics, but ethical concerns remain, researchers say
By
Aaron Dorman
Sep 22, 2023
A new meta-study on using AI within geriatrics praises AI as a “valuable asset” but still warns about the need for future research and potential ethical concerns.
Acute hospital care at home shows promise for medically complex patients
Jan 08, 2024
At 30 days after discharge, the mortality rate was 3.2% and skilled nursing facility use rate was 2.6%.
More news for Friday, Sept. 29
By
Kimberly Bonvissuto
Sep 29, 2023
Pathway Health launches workforce development initiative … Florida assisted living provider sued for pregnancy discrimination … Collaborators establish Alzheimer’s disease research center
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Legislation aims to ensure ‘fair and accurate’ Alzheimer’s treatment coverage decisions
By
Kimberly Bonvissuto
Nov 21, 2023
Federal legislation that would prevent the federal government from imposing wide-reaching coverage restrictions on Alzheimer’s treatments was reintroduced last week, providing “fair and accurate”...
Joint Commission proposes new infection control requirements for assisted living
By
Kimberly Bonvissuto
Jan 16, 2024
The Joint Commission is planning to revise its infection prevention and control requirements for assisted living community accreditation as infection prevention and control regulations for the setting...
Strategies needed to improve delivery of Alzheimer’s disease-modifying therapies
Jan 30, 2024
Models that enable primary care practitioners to diagnose disease and evaluate patients for treatment eligibility would have biggest effect on wait times, the study found.
Light therapy aids psychobehavioral symptoms with Alzheimer’s disease
Dec 08, 2023
Significant benefits were seen for sleep efficacy, depression and agitation.
Minor neuropsychological deficits indicate risk for progression to Alzheimer’s disease
Oct 13, 2023
For patients with subjective cognitive decline, those with minor neuropsychological deficits have increased cognitive decline and a risk for progression to mild cognitive impairment.